CN1772100A

CN1772100A - Medicine for treating psoriasis and its prepn

Info

Publication number: CN1772100A
Application number: CN 200510104405
Authority: CN
Inventors: 邢继华; 邢继霞
Original assignee: Individual
Current assignee: Individual
Priority date: 2005-10-26
Filing date: 2005-10-26
Publication date: 2006-05-17

Abstract

The present invention discloses one kind of medicine for treating psoriasis and its preparation process. It is prepared with ephedra, langdu root, puncture vine, flavescent sophora root, schizonepeta herb and other 14 kinds of Chinese medicinal materials, and through grinding and other steps. The medicine of the present invention has high curative effect, high safety, simple preparation process, low cost and no negative reaction.

Description

Psoriatic medicine of a kind of treatment and preparation method thereof

Technical field

The present invention relates to the psoriatic medicine of a kind of treatment, and the method for preparing this medicine.

Background technology

Psoriasis is commonly called as " psoriasis ", be a kind of chronic inflammatory disease dermatoses of common and easy recurrence, the various ages all can fall ill, with person between twenty and fifty for seeing more, it is 1.56 ‰ that China has generally investigated urbanite's prevalence, the city prevalence is higher than the rural area, because its cause of disease is not clear fully as yet, at present psoriasis is not still had specific treatment, mainly treat with oral drugs with in conjunction with external preparation, mainly be the cortical steroid immunosuppressant, tretinoin, these medicines often produce bigger side effect to the patient.

Summary of the invention

Technical problem to be solved by this invention is to provide a kind of psoriatic medicine for the treatment of safely and efficiently for the psoriatic.

Another technical problem to be solved by this invention provides a kind of method for preparing said medicine.

Medicine of the present invention is the medicament of being made by the following weight proportion raw material:

Herba Ephedrae 140～160 Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 40～60 Fructus Tribulis 280～320 Radix Sophorae Flavescentiss 150～170

Herba Schizonepetae 140～160 Radix Saposhnikoviaes 150～170 Rhizoma Atractylodis 140～160 Radix Et Rhizoma Rhei 100～140 Radix Gentianae Macrophyllae

100～140 river Qiang, 150～170 Cortex Dictamnis, 230～270 WANGJIAPI, 140～160 Radix Paeoniae Rubra

100～140 Radix Rehmanniae, 280～320 Radix Polygoni Multifloris, 80～120 Rhizoma Chuanxiongs, 100～140 Zaocys

140～160 Flos Loniceraes, 280～320 Cortex Moutans 20～40.

The proportioning of optimum weight of the present invention (part) is:

Herba Ephedrae 150 Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 50 Fructus Tribulis 300 Radix Sophorae Flavescentiss 160 Herba Schizonepetae 150

Radix Saposhnikoviae 160 Rhizoma Atractylodis 150 Radix Et Rhizoma Rhei 120 Radix Gentianae Macrophyllae 120 river Qiang 160

Cortex Dictamni 250 WANGJIAPI 150 Radix Paeoniae Rubra 120 Radix Rehmanniae 300 Radix Polygoni Multifloris 100

Rhizoma Chuanxiong 120 Zaocys 150 Flos Loniceraes 300 Cortex Moutans 30.

The preparation method that above-mentioned each component is made medicine of the present invention is:

Herba Ephedrae, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), disease Herba chenopodii, Radix Sophorae Flavescentis, Herba Schizonepetae, Radix Saposhnikoviae, Rhizoma Atractylodis, Radix Et Rhizoma Rhei, Radix Gentianae Macrophyllae, river Qiang, Cortex Dictamni, Cortex Acanthopancis, Radix Polygoni Ciliinerve, the Radix Rehmanniae, Radix Polygoni Multiflori, Rhizoma Chuanxiong, Zaocys, Flos Lonicerae, Cortex Moutan are pulverized by above-mentioned weight proportion, grind to stirring behind the smalls capsule for medicine of packing into.

Pharmacological effect: the present invention adopts Herba Ephedrae, Herba Schizonepetae, Radix Saposhnikoviae, notopterygium wind dispelling to induce sweat; Radix Paeoniae Rubra, the Radix Rehmanniae, Radix Et Rhizoma Rhei, Flos Lonicerae, Cortex Moutan, Radix Sophorae Flavescentis, Radix Polygoni Multiflori clearing away heat-fire, cooling blood and dissolving purpura; Fructus Tribuli, Zaocys, Cortex Dictamni dispelling wind for relieving itching; Rhizoma Atractylodis, Radix Gentianae Macrophyllae, Cortex Acanthopancis clearing heat and expelling damp; The Rhizoma Chuanxiong dissipating blood stasis that dispels the wind; The kind knot of Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) removing mass; The said medicine compatibility uses the energy dispelling wind for relieving itching, clearing away heat and cooling blood, and promoting blood circulation to remove obstruction in the collateral reaches expelling pathogenic factors from the exterior antipyretic and itching-stopping curative effect, this medicine taking convenience, good effect is not seen obvious adverse reaction.

In recent years, the onset of psoriasis rate has year by year the trend that rises since with person between twenty and fifty for seeing more, have a strong impact on patient's physical and mental health, the present invention provides a kind of pure Chinese medicinal preparation safely and efficiently, good effect for the psoriatic, preparation is simple, and cost is low, does not see tangible untoward reaction.

The specific embodiment

The proportioning of optimum weight of the present invention (part) is:

Rhizoma Chuanxiong 120 Zaocys 150 Flos Loniceraes 300 Cortex Moutans 30.

Herba Ephedrae, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), disease Herba chenopodii, Radix Sophorae Flavescentis, Herba Schizonepetae, Radix Saposhnikoviae, Rhizoma Atractylodis, Radix Et Rhizoma Rhei, Radix Gentianae Macrophyllae, river Qiang, Cortex Dictamni, Cortex Acanthopancis, Radix Polygoni Ciliinerve, the Radix Rehmanniae, Radix Polygoni Multiflori, Rhizoma Chuanxiong, Zaocys, Flos Lonicerae, Cortex Moutan are pulverized by above-mentioned weight proportion, grind to stirring behind the smalls, the capsule for medicine of packing into, each 4-6 grain of being grown up, oral every day 3 times, serveing on two weeks is a course of treatment.

Observation of curative effect: 8 weeks of mean treatment of the present invention, clinical observation psoriatic 108 examples, 67 examples of fully recovering, produce effects 22 examples, 11 examples that take a turn for the better, invalid 8 examples, total effective rate 82.4%.

Late result observation to 45 examples of curing, was followed up a case by regular visits at 12-24 month, alleviated 29 examples, recurred 11 examples, slightly recurred 5 examples.

Model case

Lee XX, the man, 32 years old, Zhong Lou town, Juxian County XX people from village, the patient is surplus because of whole body squama erythema companion pruritus 2 years, goes to a doctor on November 8th, 2003, before 2 years, the patient does not have obvious inducement, the aquatic foods bits property erythema companion pruritus of nail cover size occurs at trunk, go to a doctor, examine to " psoriasis " and give oral medicine and medicine for external use treatment (concrete medicine name and dosage are not quite clear) skin lesion take a favorable turn slightly in local clinic, heavy when light when satisfying the back state of an illness, nearly a year and a half, skin lesion spreaded all over two upper and lower extremities, and the patient satisfies and comes my section to go to a doctor the routine urinalysis of having a blood test, Chest X-rays, hepatic and renal function is no abnormal, give each 5 of this medicament, 3 times on the 1st, serve on for 4 weeks, it disappears skin lesion, skin lesion disappears fully after obeying for 4 weeks again, follows up a case by regular visits to and does not see recurrence in 1 year.

Claims

1. treat psoriatic medicine for one kind, it is characterized in that it is the medicament of being made by the following weight proportion raw material:

Herba Schizonepetae 140～160 Radix Saposhnikoviaes 150～170 Rhizoma Atractylodis 140～160 Radix Et Rhizoma Rhei 100～140

Radix Gentianae Macrophyllae 100～140 river Qiang 150～170 Cortex Dictamnis, 230～270 WANGJIAPI 140～160

Radix Paeoniae Rubra 100～140 Radix Rehmanniae 280～320 Radix Polygoni Multifloris 80～120 Rhizoma Chuanxiongs 100～140

Zaocys 140～160 Flos Loniceraes 280～320 Cortex Moutans 20～40.

2. the psoriatic medicine of a kind of treatment as claimed in claim 1, it is characterized in that: wherein the weight proportion of each raw material is:

Rhizoma Chuanxiong 120 Zaocys 150 Flos Loniceraes 300 Cortex Moutans 30.

3. the described a kind of preparation method for the treatment of psoriatic medicine of claim 2, it is characterized in that: Herba Ephedrae, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), disease Herba chenopodii, Radix Sophorae Flavescentis, Herba Schizonepetae, Radix Saposhnikoviae, Rhizoma Atractylodis, Radix Et Rhizoma Rhei, Radix Gentianae Macrophyllae, river Qiang, Cortex Dictamni, Cortex Acanthopancis, Radix Polygoni Ciliinerve, the Radix Rehmanniae, Radix Polygoni Multiflori, Rhizoma Chuanxiong, Zaocys, Flos Lonicerae, Cortex Moutan are pulverized by above-mentioned weight proportion, grind to stirring behind the smalls capsule for medicine of packing into.